As from October onwards, AqVida, located in Hamburg, will be also present in the south of Germany. With the new office in Bavaria, AqVida further optimises its production chain.

The crucial indicator for opening the second office was the idea of accompanying the external packaging processes even more closely. In Oberhaching, AqVida is sited right next to its external and independent packaging partner Comphass, to better integrate the last step of production chain in its processes.

"Not only Germany and Europe have high expectations in the packaging of a pharmaceutical product", says Wolfgang Heinze, CEO of AqVida. "Also less regulated markets are increasingly asking for high quality finished products whith German appearance." Double-digit growth rates of oncology products also make the decision reasonable for the company economically.

AqVida is a pharmaceutical company focusing on development, registration, and licensing of oncology products. Its portfolio includes Paclitaxel, Oxaliplatin and Docetaxel. The company is based in Hamburg, Bavaria and Hangzhou, China.